Showing results (71-80 of 555) with videos related to
Sort By:
Pageof 56
The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 22, 2009
Ectopic pregnancy: challenging accepted management strategiesGeorge CondousThe Australian & New Zealand Journal of Obstetrics & Gynaecology|February 16, 2008
Enough is enough! Time for a new model of care for women with early pregnancy complicationsGeorge CondousExpert Opinion on Drug Metabolism & Toxicology|July 6, 2017
Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomasSimone Ferrero, Umberto Leone Roberti Maggiore, Nicoletta Aiello, et al.Expert Opinion on Drug Safety|February 3, 2026
Safety and efficacy of hormonal therapies used to treat endometriosis in women suffering migraineUmberto Perrone, Fabio Barra, Giulio Evangelisti, et al.Current Opinion in Obstetrics & Gynecology|January 3, 2020
Hysteroscopic endometrial resection vs. hysterectomy for abnormal uterine bleeding: impact on quality of life and sexuality. Evidence from a systematic review of randomized controlled trialsSalvatore G Vitale, Simone Ferrero, Michal Ciebiera, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 14, 2025
Uterine "twisting sign": A new potential ultrasonographic soft marker for deep endometriosisFabio Barra, Simone Ferrero, Umberto Perrone, et al.Expert Opinion on Pharmacotherapy|June 26, 2026
GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectivesSimone Ferrero, Irene Gazzo, Umberto Perrone, et al.Expert Opinion on Emerging Drugs|December 15, 2023
A review of phase II and III drugs for the treatment and management of endometriosisUmberto Perrone, Giulio Evangelisti, Antonio Simone Laganà, et al.Expert Opinion on Drug Metabolism & Toxicology|June 30, 2020
Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosisLuigi Della Corte, Fabio Barra, Antonio Mercorio, et al.Pathology, Research and Practice|April 5, 2025
The role of the Androgen Receptor (AR) in endometrial cancer aggressiveness: Correlation with other prognostic markers and therapeutic implications. A retrospective observational studyMichele Paudice, Marco Greppi, Luca Valle, et al.Pageof 56